Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Lulla PD, Naik S, Vasileiou S, Tzannou I, Watanabe A, Kuvalekar M, Lulla S, Carrum G, Ramos CA, Kamble R, Hill L, Randhawa J, Gottschalk S, Krance R, Wang T, Wu M, Robertson C, Gee AP, Chung B, Grilley B, Brenner MK, Heslop HE, Vera JF, Leen AM.
Lulla PD, et al.
Blood. 2021 May 13;137(19):2585-2597. doi: 10.1182/blood.2020009471.
Blood. 2021.
PMID: 33270816
Free PMC article.
Clinical Trial.